Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,209 | 295 | 96.2% |
| Education | $288.31 | 4 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,222 | 69 | $0 (2024) |
| Novo Nordisk Inc | $896.32 | 46 | $0 (2024) |
| Astellas Pharma US Inc | $699.27 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $693.21 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $583.06 | 19 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $390.65 | 9 | $0 (2023) |
| Lilly USA, LLC | $301.01 | 24 | $0 (2024) |
| Hologic Sales and Service, LLC | $296.95 | 2 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $251.95 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $250.40 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $476.18 | 16 | ABBVIE INC. ($318.23) |
| 2023 | $2,466 | 110 | ABBVIE INC. ($557.89) |
| 2022 | $3,361 | 118 | ABBVIE INC. ($968.10) |
| 2021 | $1,194 | 55 | Novo Nordisk Inc ($379.58) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Biological | ||||||
| 07/31/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $123.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Inflammation | ||||||
| 04/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Diabetes Care | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes Care | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Biological | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.50 | General |
| 12/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: GI | ||||||
| 12/11/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Inflammation | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.55 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 150 | 215 | $32,635 | $11,082 |
| 2022 | 6 | 232 | 384 | $39,105 | $16,621 |
| 2021 | 4 | 152 | 208 | $21,305 | $10,898 |
| 2020 | 1 | 12 | 22 | $3,432 | $912.24 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 130 | $18,800 | $5,808 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 32 | $7,540 | $2,592 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $5,280 | $1,957 | 37.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 16 | 16 | $730.00 | $663.41 | 90.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 14 | 19 | $285.00 | $60.99 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 265 | $29,150 | $12,604 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $7,200 | $3,395 | 47.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 20 | 20 | $600.00 | $318.76 | 53.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 26 | 40 | $600.00 | $129.18 | 21.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,360 | $129.01 | 9.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 13 | $195.00 | $44.59 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 121 | $13,310 | $7,093 | 53.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $6,720 | $3,271 | 48.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 26 | 26 | $780.00 | $425.62 | 54.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 23 | 33 | $495.00 | $108.24 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 22 | $3,432 | $912.24 | 26.6% |
About Noemi Cabrera, APRN
Noemi Cabrera, APRN is a Family healthcare provider based in North Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1558872986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Noemi Cabrera, APRN has received a total of $7,497 in payments from pharmaceutical and medical device companies, with $476.18 received in 2024. These payments were reported across 299 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,209).
As a Medicare-enrolled provider, Cabrera has provided services to 546 Medicare beneficiaries, totaling 829 services with total Medicare billing of $39,513. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location North Las Vegas, NV
- Active Since 10/12/2017
- Last Updated 05/02/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558872986
Products in Payments
- UBRELVY (Drug) $645.61
- FARXIGA (Drug) $566.70
- CREON (Drug) $528.85
- JARDIANCE (Drug) $499.39
- QULIPTA (Drug) $402.91
- LINZESS (Drug) $391.93
- ZENPEP (Drug) $390.65
- Ozempic (Drug) $353.74
- APTIMA (Device) $296.95
- Rybelsus (Drug) $294.99
- Linzess (Drug) $251.95
- Myrbetriq (Drug) $224.75
- MOUNJARO (Drug) $218.15
- RYBELSUS (Drug) $159.40
- Veozah (Drug) $145.76
- BELSOMRA (Drug) $138.98
- XIFAXAN (Drug) $134.37
- Otezla (Drug) $108.80
- FREESTYLE LIBRE 3 (Device) $86.93
- NEXLIZET (Drug) $78.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in North Las Vegas
Ms. Devra Hamilton, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $10,097
Fiorella Rocca, Aprn, APRN
Family — Payments: $6,474
Mr. Pius Ehiane, Aprn, Fnp, Pmhnp-Bc, APRN, FNP, PMHNP-BC
Family — Payments: $3,539
Maria Gochioco
Family — Payments: $2,882
Daphnie Joseph, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $2,287
Lindsay Manjarres, Fnp-Bc, FNP-BC
Family — Payments: $1,531